Schweizer Eliane, Hoffmann-Röder Anja, Schärer Kaspar, Olsen Jacob A, Fäh Christoph, Seiler Paul, Obst-Sander Ulrike, Wagner Björn, Kansy Manfred, Diederich François
Laboratorium für Organische Chemie, ETH Zürich, Hönggerberg, HCI, 8093 Zürich, Switzerland.
ChemMedChem. 2006 Jun;1(6):611-21. doi: 10.1002/cmdc.200600015.
A series of 16 tricyclic thrombin inhibitors was prepared by using the 1,3-dipolar cycloaddition of azomethine ylides derived from 3- or 4-hydroxyproline and 4-bromobenzaldehyde, with N-(4-fluorobenzyl)maleimide as the key step. The terminal pyrrolidine ring of the inhibitors was systematically substituted to explore the potential bioisosteric behavior of C-F, C-OH, and C-OMe residues pointing into the environment of the catalytic center of a serine protease. X-ray crystal structure analyses revealed a distinct puckering preference of this ring. Substitution by F, HO, and MeO has a strong effect on the basicity of the adjacent pyrrolidine nitrogen center which originates from two sigma-inductive pathways between this center and the electronegative O and F atoms. gem-Difluorination decreases the pKa value of this tertiary amine center to <2, making the conjugated ammonium ion a moderately strong acid. Unexpectedly, F substitution next to the nitrogen center reduced the lipophilicity of the ligands, as revealed by measurements of the logarithmic partition coefficient log D. The biological assays showed that all compounds are thrombin inhibitors with activities between Ki=0.08 and 2.17 microM. Bioisosteric behavior of F, HO, and MeO substituents was observed. Their electronegative F and O atoms undergo energetically similar polar interactions with positively polarized centers, such as the N atom of His 57 which is hydrogen bonded to the catalytic Ser 195. However, for energetically similar polar interactions of C-F, C-OH, and C-OMe to occur, sufficient space is necessary for the accommodation of the Me group of the C-OMe residue, and a H-bond acceptor must be present to prevent unfavorable desolvation of the C-OH residue.
以3-或4-羟基脯氨酸与4-溴苯甲醛衍生的甲亚胺叶立德与N-(4-氟苄基)马来酰亚胺进行1,3-偶极环加成反应为关键步骤,制备了一系列16种三环凝血酶抑制剂。对抑制剂的末端吡咯烷环进行系统取代,以探索指向丝氨酸蛋白酶催化中心环境的C-F、C-OH和C-OMe残基的潜在生物电子等排行为。X射线晶体结构分析揭示了该环明显的褶皱偏好。F、HO和MeO取代对相邻吡咯烷氮中心的碱性有强烈影响,这源于该中心与电负性O和F原子之间的两条σ-诱导途径。偕二氟取代使该叔胺中心的pKa值降至<2,使共轭铵离子成为中等强度的酸。如对数分配系数log D的测量所示,氮中心旁边的F取代意外地降低了配体的亲脂性。生物学测定表明,所有化合物都是凝血酶抑制剂,活性在Ki = 0.08至2.17 μM之间。观察到F、HO和MeO取代基的生物电子等排行为。它们的电负性F和O原子与带正电的中心发生能量相似的极性相互作用,例如与催化性Ser 195氢键结合的His 57的N原子。然而,为了使C-F、C-OH和C-OMe发生能量相似的极性相互作用,需要有足够的空间来容纳C-OMe残基的Me基团,并且必须存在一个氢键受体以防止C-OH残基发生不利的去溶剂化。